Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou 450046, China.
1 Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou 450046, China.
J Tradit Chin Med. 2023 Oct;43(6):1126-1139. doi: 10.19852/j.cnki.jtcm.20230517.003.
To explore the underlying mechanisms of the effects of Yangqing Chenfei formula (, YCF) on inflammation and fibrosis in silicosis inhibition of macrophage polarization.
A silicotic rat model was established a single intratracheal instillation of silica particles on the first day of week 0. Subsequently, YCF was administered intragastrically to silicotic rats during weeks 0-2 and 5-8 twice daily. The mouse-derived alveolar macrophage cell line was used to investigate the mechanisms of YCF in M1/M2 polarization.
YCF treatment effectively inhibited lung pathological changes, including inflammatory cell infiltration and tissue damage, and increased the forced expiratory volume in the first 0.3 s, functional residual capacity, and maximal mid-expiratory flow in weeks 2 and 8. Furthermore, the treatment improved lung functions by upregulating tidal volume, pause increase, and expiratory flow at 50% tidal volume from weeks 5 to 8. Moreover, YCF could significantly suppressed the progression of inflammation and fibrosis, by reducing the levels of inflammatory cytokines, as well as collagen- I and III. YCF treatment also decreased the numbers of macrophages and M1/M2 macrophages and the level of transforming growth factor-β (TGF-β). Additionally, YCF5, the effective substance in YCF, decreased lipopolysaccharide and interferon-γ-induced M1 macrophage polarization in a concentration-dependent manner. The mechanism of anti-M1 polarization might be related to a decrease in extracellular signal-regulated kinase, c-JUN N-terminal kinase, P38, and P65 phosphorylation. Furthermore, YCF5 inhibited interleukin-4-induced M2 macrophages by decreasing the protein and mRNA expressions of arginase-1 and CD206 as well as the levels of profibrotic factors, such as TGF-β and connective tissue growth factor. The mechanisms underlying the anti-M2 polarization of YCF5 were primarily associated with the inhibition of the nuclear translocation of phosphorylated signal transducer and activator of transcription 6 (p-STAT6).
YCF significantly inhibits inflammation and fibrosis in silicotic rats probably the suppression of M1/M2 macrophage polarization mediated by the inhibition of mitogen-activated protein kinase and nuclear factor kappa B signaling pathways and Janus kinase/STAT6 pathways.
探讨阳春清肺方(YCF)通过抑制巨噬细胞极化抑制矽肺炎症和纤维化的潜在机制。
采用气管内单次滴注二氧化硅颗粒的方法,于第 0 天建立矽肺大鼠模型。随后,在第 0-2 周和第 5-8 周,每天两次通过灌胃给予矽肺大鼠 YCF。采用小鼠肺泡巨噬细胞系研究 YCF 在 M1/M2 极化中的作用机制。
YCF 治疗可有效抑制肺部病理变化,包括炎性细胞浸润和组织损伤,并在第 2 周和第 8 周增加第 0.3 秒用力呼气容积、功能残气量和最大中期呼气流速。此外,YCF 还可通过增加第 5 周到第 8 周的潮气量、呼气暂停增加和 50%潮气量时的呼气流量来改善肺功能。此外,YCF 还可显著抑制炎症和纤维化的进展,降低炎症细胞因子以及胶原 I 和胶原 III 的水平。YCF 治疗还可减少巨噬细胞和 M1/M2 巨噬细胞的数量以及转化生长因子-β(TGF-β)的水平。此外,YCF5(YCF 的有效物质)可呈浓度依赖性降低脂多糖和干扰素-γ诱导的 M1 巨噬细胞极化。抗 M1 极化的机制可能与细胞外信号调节激酶、c-JUN N-末端激酶、P38 和 P65 磷酸化减少有关。此外,YCF5 通过降低白细胞介素 4 诱导的 M2 巨噬细胞中精氨酸酶 1 和 CD206 的蛋白和 mRNA 表达以及 TGF-β和结缔组织生长因子等促纤维化因子的水平,抑制 M2 极化。YCF5 抗 M2 极化的机制主要与抑制磷酸化信号转导和转录激活因子 6(p-STAT6)的核转位有关。
YCF 可显著抑制矽肺大鼠的炎症和纤维化,可能是通过抑制丝裂原活化蛋白激酶和核因子 κB 信号通路以及 Janus 激酶/STAT6 通路抑制 M1/M2 巨噬细胞极化所致。